The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Abstract
14-3-3Sigma is a member of a family of proteins that regulate cellular activity by binding and sequestering phosphorylated proteins. It has been suggested that 14-3-3sigma promotes pre-mitotic cell-cycle arrest following DNA damage, and that its expression can be controlled by the p53 tumour suppressor gene. Here we describe an improved approach to the generation of human somatic-cell knockouts, which we have used to generate human colorectal cancer cells in which both 14-3-3sigma alleles are inactivated. After DNA damage, these cells initially arrested in the G2 phase of the cell cycle, but, unlike cells containing 14-3-3sigma, the 14-3-3sigma-/- cells were unable to maintain cell-cycle arrest. The 14-3-3sigma-/- cells died ('mitotic catastrophe') as they entered mitosis. This process was associated with a failure of the 14-3-3sigma-deficient cells to sequester the proteins (cyclin B1 and cdc2) that initiate mitosis and prevent them from entering the nucleus. These results may indicate a mechanism for maintaining the G2 checkpoint and preventing mitotic death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SFN (14-3-3 sigma) encodes for a protein that removes cell cycle proteins from the nucleus and is also required for the G2/M arrest.51, 157”
From Census and evaluation of p53 target genes (2017) · cites this paper as [157]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Self-citationRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Self-citationUniversal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798
CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals
Fornerod, M. W. J., Ohno, M., Yoshida, M., & Mattaj, I. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80371-2 · Cited by 2,086
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citationCRM1 is responsible for intracellular transport mediated by the nuclear export signal
Fukuda, M., Asano, S., Nakamura, T., Adachi, M., Yoshida, M., Yanagida, M., & Nishida, E. (1997) · Nature · doi:10.1038/36894 · Cited by 1,213
p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
Waldman, T. A., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 1,188
Self-citationKip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 895
DNA methylation patterns of the S100A14, POU2F3 and SFN genes in equine sarcoid tissues
Semik‐Gurgul, E., Ząbek, T., Fornal, A., Wnuk, M., Pawlina‐Tyszko, K., Gurgul, A., Klukowska‐Rötzler, J., Koch, C., Mählmann, K., & Bugno‐Poniewierska, M. (2018) · Research in Veterinary Science · doi:10.1016/j.rvsc.2018.07.006 · Cited by 8
Using TUNEL Assay to Quantitate p53-Induced Apoptosis in Mouse Tissues
Resnick‐Silverman, L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1217-0_12 · Cited by 8
Lee, S. F., Hirpara, J. L., Qu, J., Yadav, S. K., Sachaphibulkij, K., & Pervaiz, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.11.025 · Cited by 8
Yao, Y.-W., Shi, Y., Jia, Z.-F., Jiang, Y.-H., Gu, Z., Wang, J., Aljofan, M., & Sun, Z.-G. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0825-z · Cited by 8
Ianzini, F., & Mackey, M. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-221-2_4 · Cited by 8
Yoon, N. K., Seligson, D. B., Chia, D., Elshimali, Y., Sulur, G., Ai, L., Horvath, S., Maresh, E. L., Mah, V. H., Bose, S., et al. (2009) · Cancer Biomarkers · doi:10.3233/cbm-2009-0106 · Cited by 8
Intriguing Self-Assembly of Large Granules of F-Actin Facilitated by Gelsolin and α-Actinin
Tang, J. X., Kang, H., & Jia, J. (2005) · Langmuir · doi:10.1021/la047213c · Cited by 8
Higginbottom, K., Jahnke, U., Newland, A. C., Cotter, F. E., & Allen, P. D. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0104-6 · Cited by 8
Superhelical DNA as a preferential binding target of 14-3-3γ protein
Brázda, V., Čechová, J., Coufal, J., Rumpel, S., & Jagelská, E. B. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.682205 · Cited by 8
Zhang, Y., Bickle, Q. D., & TAYLOR, M. G. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00086-2 · Cited by 8
Chapter 14. Cell cycle kinases and checkpoint regulation in cancer
Kimball, S. D., & Webster, K. R. (2001) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(01)36054-2 · Cited by 8
Analysis of c-Jun N-Terminal Kinase Regulation and Function
Hall, J. P., & Davis, R. J. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)45034-3 · Cited by 8
Role of 14‐3‐3σ in resistance to cisplatin in non‐small cell lung cancer cells
Çetintaş, V. B., Vardarli, A. T., Çok, G., Küçükaslan, A. Ş., Kosova, B., Gündüz, C., Veral, A., & Eroğlu, Z. (2012) · Cell Biology International · doi:10.1002/cbin.10006 · Cited by 7
O’Neal, K. R., & Agah, R. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-030-0_17 · Cited by 7
Toxoplasma gondii: Effect of infection on expression of 14-3-3 proteins in human epithelial cells
Monroy, F. P. (2007) · Experimental Parasitology · doi:10.1016/j.exppara.2007.07.008 · Cited by 7
Radiation response and cell cycle regulation of p53 rescued malignant keratinocytes
Niemantsverdriet, M., Jongmans, W., & Backendorf, C. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.016 · Cited by 7
Syrjänen, S., Naud, P., Sarian, L. O., Derchain, S., Roteli-Martins, C. M., Longatto‐Filho, A., Tatti, S., Branca, M., Eržen, M., Hammes, L. S., et al. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcp49doitydctqj · Cited by 7
Lee, M., & Yoo, H. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21199 · Cited by 7
Zhang, C., Zhang, C., He, Y., & Hang, H. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000149808 · Cited by 7
p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb
Yamane, K., Katayama, E., & Tsuruo, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204408 · Cited by 7
14-3-3 Gene expression in regenerating rat liver after 2/3 partial hepatectomy
Xue, D., Guo, X., Chen, R., Niu, Z., & Xu, C. (2015) · Genetics and Molecular Research · doi:10.4238/2015.march.20.12 · Cited by 7
DNA defects target the centrosome
Vidwans, S. J., & Su, T. T. (2000) · Nature Cell Biology · doi:10.1038/35000099 · Cited by 7
Cosgrove, D., Park, B. H., & Vogelstein, B. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm005 · Cited by 7
Self-citationHarnessing Immunogenic Cell Death to Boost the Impact of Radiation Therapy
Mannion, J., & Meier, P. (2025) · The Cancer Journal · doi:10.1097/ppo.0000000000000780 · Cited by 6
Mogal, M. R., Junayed, A., Mahmod, M. R., Sompa, S. A., Lima, S. A., Kar, N., TasminaTarin, Khatun, M., Zubair, M. A., & Sikder, M. A. (2022) · BioMed Research International · doi:10.1155/2022/1617989 · Cited by 6
In Silico Studies on GCP-Lys-OMe as a Potential 14-3-3σ Homodimer Stabilizer
Aljabal, G., & Yap, B. K. (2022) · Pharmaceuticals · doi:10.3390/ph15101290 · Cited by 6
Ye, Y., Xiao, Y. Q., Wang, W., Gao, J.-X., Yearsley, K. H., Yan, Q., & Barsky, S. H. (2012) · Oncotarget · doi:10.18632/oncotarget.479 · Cited by 6
Jacquet, P., Buset, J., Vankerkom, J., Baatout, S., de Saint‐Georges, L., Schoonjans, W., & Desaintes, C. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-093 · Cited by 6
Proteomic approaches for investigation of therapy resistance in cancer
Lage, H. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800162 · Cited by 6
Identification and Distribution of 14.3.3σ (Stratifin) in the Human Cornea
Zanello, S. B., Nayak, R. C., Zanello, L. P., & Farthing-Nayak, P. J. (2006) · Current Eye Research · doi:10.1080/02713680600878816 · Cited by 6
Daniel, P. T. (2003) · Springer eBooks · doi:10.1007/978-3-642-59343-7_5 · Cited by 5
Zhong, C., Lei, Y., Zhang, J., Zheng, Q., Liu, Z., Xu, Y., Shan, S., & Ren, T. (2024) · Biomedicines · doi:10.3390/biomedicines12061246 · Cited by 5
Vogel, S., & Herzinger, T. (2013) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12071 · Cited by 5
Hornerin mediates phosphorylation of the polo-box domain in Plk1 by Chk1 to induce death in mitosis
Song, H., Kim, E. H., Hong, J., Gwon, D., Kim, J. W., Bae, G., & Jang, C. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01208-y · Cited by 6
Huynh, H. T., Nguyen, T., Panasci, L., & Do, P. (2004) · Cancer · doi:10.1002/cncr.20670 · Cited by 5
Regulation of Cell Cycle Progression
Scorah, J., & McGowan, C. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00302-8 · Cited by 6
Yun, W., Kim, J. E., Jin, Y. J., Roh, Y. J., Song, H. J., Seol, A., Kim, T. R., Min, K. S., Park, E. S., Park, G. H., et al. (2023) · Laboratory Animal Research · doi:10.1186/s42826-023-00175-2 · Cited by 5
p53 Protein and Nonmelanoma Skin Cancer
Melnikova, V. O., & Ananthaswamy, H. N. (2007) · Springer eBooks · doi:10.1007/0-387-35098-5_8 · Cited by 5
Francis, D. A. (2003) · Advances in botanical research · doi:10.1016/s0065-2296(05)40004-x · Cited by 5
Methylation Patterns and Chemosensitivity in NSCLC
Ramírez, J. L., Salazar, M., Gupta, J. R. P., Sánchez, J. M., Tarón, M., Sánchez-Ronco, M., Alberola, V., & Peñas, R. D. L. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-5133-3_17 · Cited by 5
Human Somatic Cell Gene Targeting
Waldman, T. A., Lee, C. S., Nishanian, T. G., & Kim, J. (2003) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb0915s62 · Cited by 5
Hong, H.-Y., Jeon, W.-K., Kim, S., & Kim, B.-C. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.123 · Cited by 5
Molin, S., Grgic, M., Ruzicka, T., & Herzinger, T. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12309 · Cited by 5
Nalepa, G., & Harper, J. W. (2002) · Nature Medicine · doi:10.1038/nm0702-661 · Cited by 5
Negative growth regulators of the cell cycle machinery and cancer
Zhang, M., & Yang, H. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.02.004 · Cited by 5
THE CELL CYCLE AND ITS RELEVANCE TO THE UROLOGIST
DeWolf, W. C., & Gaston, S. M. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000115505.95189.24 · Cited by 5
Efp as a new molecular target for breast cancer therapy
Horie, K., Urano, T., & Inoue, S. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200301000-00001 · Cited by 5
Wynshaw-Boris, A. J. (2007) · Nature · doi:10.1038/446274a · Cited by 5
Serial Analysis of Gene Expression in Neurofibromatosis Type 2–Associated Vestibular Schwannoma
Halum, S. L., Popper, P., Cioffi, J. A., & Wackym, P. A. (2004) · Otology & Neurotology · doi:10.1097/00129492-200407000-00028 · Cited by 5
Souza, R. D., Ayub, L. C., & Yip, K. W. (2018) · Wiley eBooks · doi:10.1002/9781119432463.ch23 · Cited by 5
Chow, J. P. H., & Poon, R. Y. C. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1770-6_5 · Cited by 4
In Silico Prediction and Biophysical Validation of Novel 14-3-3σ Homodimer Stabilizers
Aljabal, G., Teh, A.-H., & Yap, B. K. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00791 · Cited by 4
Lin, Y., Tang, W., Huang, P., Wang, Z., Duan, L., Jia, C., Sun, R., Liu, L., & Shen, J. (2023) · Developmental Dynamics · doi:10.1002/dvdy.682 · Cited by 4
Rodzaje śmierci komórki The types of cell death
Izdebska, M., & Grzanka, A. (2007) · Cited by 4
Chapter 12. Intracellular signaling targets for cancer chemosensitization
Gesner, T. G., & Harrison, S. D. (2002) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(02)37013-1 · Cited by 4
Huang, H.-H., Chen, C., Sc, H., Yang, C.-H., & Hwang, C.-F. (2014) · The Journal of Laryngology & Otology · doi:10.1017/s0022215113003447 · Cited by 4
Molecular Pathogenesis of Basal Cell Carcinoma
Meyer, T. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-78574-5_17 · Cited by 4
Investigation of the Skin Aging Mechanism Focusing on Stratifin
Adachi, H., Murakami, Y., Hotta, N., Tanaka, H., & Nakata, S. (2015) · Journal of Society of Cosmetic Chemists of Japan · doi:10.5107/sccj.49.211 · Cited by 4
Molecular Genetics of Lung and Pleural Neoplasms
Cagle, P. T., Jagirdar, J. S., & Popper, H. (2008) · Springer eBooks · doi:10.1007/978-0-387-72114-9_2 · Cited by 4
Ford, H. L., & Pardee, A. B. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0001 · Cited by 4
Poon, R. Y. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30053-0 · Cited by 4
14-3-3 Proteins in Brain function
Takahashi, Y. (2006) · Springer eBooks · doi:10.1007/0-387-30395-2_12 · Cited by 3
Sun, L., Ain, Q. U., Gao, Y., Khan, G. J., Yuan, S., & Roy, D. (2019) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2019.03.002 · Cited by 3
Targeting SERCA2 in Anti-Tumor Drug Discovery
Song, W., Zhang, Q., Cao, Z., Guo, J., Zhan, T., Yuan, Y., Kang, N., & Zhang, Q. (2024) · Current Drug Targets · doi:10.2174/0113894501325497240918042654 · Cited by 3
CpG Island Hypermethylation in Breast Cancer Progression and Metastasis
Parrella, P. (2005) · Springer eBooks · doi:10.1007/1-4020-3642-6_5 · Cited by 2
Cell Cycle and DNA Damage Response in Postmitotic Neurons
Kruman, I. I. (2011) · InTech eBooks · doi:10.5772/20859 · Cited by 3
Liu, B., Zhang, H., Xie, Y., Hao, J., Duan, X., Zhou, Q., Qiu, R., & Zhou, G. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328220ebeb · Cited by 3
PAR-5is a PARty hub in the germline
Aristizábal-Corrales, D., Schwartz, S., & Cerón, J. (2013) · Worm · doi:10.4161/worm.21834 · Cited by 3
Enhanced cell death by AdCMV-p53 after irradiation of HeLa cells with 12C6+ ions
Liu, B., Zhang, H., Zhou, G., Xie, Y., Hao, J., Zhou, Q., Duan, X., & Qiu, R. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.08.012 · Cited by 3
Differentiating Chromosome Fragmentation and Premature Chromosome Condensation
Stevens, J. B., & Heng, H. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6558-4_5 · Cited by 3
Mechanisms of G2 Phase Arrest in DNA Damage-Induced Checkpoint Response
Kuang, J., & Wang, R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_3 · Cited by 3
Somatic Cell Knockouts of Tumor Suppressor Genes
Hemmer, R. M., Wei, W., Dutriaux, A., & Sedivy, J. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-329-1:187 · Cited by 3
Radiation Biology for Radiation Oncologists
Chan, T. A.-T., Hristov, B. D., & Powell, S. N. (2017) · Wiley eBooks · doi:10.1002/9781119341154.ch2 · Cited by 3
Self-citationSakuma, N., Abe, M., Ishii, D., Kawasaki, T., Arakawa, N., Matsuyama, S., Saito, Y., Suzuki, T., & Tatsumi, K. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03184-6 · Cited by 3
Cell Cycle Control and Check Points in Hematopoietic Stem Cells
Ruscetti, F. W., & Bartelmez, S. H. (2004) · Elsevier eBooks · doi:10.1016/b978-012436643-5/50100-0 · Cited by 2
Telomere Metabolism and DNA Damage Response
Pandita, T. K. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_7 · Cited by 2
DNA Repair, Cancer and Cancer Therapy - The Current State of Art
İşbir, T., Demircan, B., Kıraç, D., Dalan, A. B., & Görmüş, U. (2011) · InTech eBooks · doi:10.5772/24147 · Cited by 2
Constitutive Photomorphogensis Protein1 (COP1) mediated p53 pathway and its oncogenic role
Rabbani, M. G., Hossain, S. A., Islam, K. K., & Uddin, S. N. (2014) · Biomedical Research and Therapy · doi:10.7603/s40730-014-0022-5 · Cited by 1
Akhlaghipour, I., Bina, A. R., Abbaszadegan, M. R., & Moghbeli, M. (2021) · Genes and Environment · doi:10.1186/s41021-021-00187-1 · Cited by 2
Role of Tumor Suppressors in DNA Damage Response
Zhou, B. S., Mattern, M. R., & Khanna, K. K. (2003) · Humana Press eBooks · doi:10.1385/1-59259-329-1:39 · Cited by 2
Molecular and Cellular Basis of Chemoresistance in Ovarian Cancer
Asare-Werehene, M., Shieh, D., Song, Y. S., & Tsang, B. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00035-2 · Cited by 4
Pandita, T. K. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)08004-x · Cited by 2
Hung, H., Chow, P. K. H., Soo, K. C., Panasci, L. C., & Hung, N. T. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20336 · Cited by 2
Satō, H., Nakamura, Y., & Motokura, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.004 · Cited by 2
Knops, K. (2013) · DuEPublico (University of Duisburg-Essen) · Cited by 2
Roninson, I. B. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_3779 · Cited by 2
Lichawska-Cieślar, A., Szukała, W., Eckhart, L., & Jura, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-18468-y · Cited by 1
Kummar, S., Song, Z., Reiss, K. A., Ford, J. M., Chen, L., Rolig, A. S., Zwiebel, J. A., Gore, S., Gray, R. J., Wang, V., et al. (2026) · JCO Precision Oncology · doi:10.1200/po-25-00769 · Cited by 1
Compounds that Abrogate the G2 Checkpoint
Kawabe, T. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-274-8_5 · Cited by 1
DNA Damage Response and Repair: Insights into Strategies for Radiation Sensitization
Joshua, D., Kristopher, T., Ng, K., Carter, B. S., Kesari, S., & Clark, C. (2011) · InTech eBooks · doi:10.5772/25216 · Cited by 1
Aberrant overexpression of an epithelial marker, 14-3-3σ, in a subset of hematological malignancies
Motokura, T., Nakamura, Y., & Satō, H. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-217 · Cited by 1
DNA Damage-Dependent Apoptosis
Skórski, T. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-199-4_12 · Cited by 1
14-3-3ζ constrains insulin secretion by regulating mitochondrial function in pancreatic β-cellsPreprint
Mugabo, Y., Zhao, C., Tan, J., Ghosh, A., Campbell, S., Fadzeyeva, E., Paré, F., Pan, S., Galipeau, M., Ast, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.17.464702 · Cited by 1
Tsai, W., & Barton, M. C. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_23 · Cited by 1
Characterization of stem cell subtypes and prognostic signature in hepatocellular carcinoma
Qiu, C., Wu, H., & Shi, W. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05239-3 · Cited by 1
Pathogenesis of Nonmelanoma Skin Cancer
Boukamp, P. (2010) · Springer eBooks · doi:10.1007/978-3-642-05072-5_8 · Cited by 1
Cell Cycle Regulation and DNA Damage
Sakasai, R., & Tibbetts, R. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_5 · Cited by 1
Evaluating the Importance of Apoptosis and Other Determinants of Cell Death and Survival
Wouters, B. G., & Chiu, R. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-221-2_3 · Cited by 1
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2009) · Springer eBooks · doi:10.1007/978-3-540-79725-8_4 · Cited by 2
Perturbations of Cellular Functions by Topoisomerase II Inhibitors
Larsen, A. K., PhD, D., Składanowski, A., & DSc, P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-221-2_21 · Cited by 1
Metadata
- Authors
- Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Vogelstein, Bert
- Venue
- Nature
- Published
- 1999-10-07
- Volume
- 401
- Issue
- 6753
- Pages
- 616-620
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2130603065
- Cited by
- 895
- References
- 20
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 15 · 2022: 10 · 2021: 16 · 2020: 21 · 2019: 8 · 2018: 8 · 2017: 16 · 2016: 10 · 2015: 19 · 2014: 31 · 2013: 30 · 2012: 30
- FWCI
- 21.59
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-08-22)
- Open access
- closed
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › 14-3-3 protein interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- 14-3-3 sigma, mitotic catastrophe, DNA damage, G2 checkpoint, cell cycle arrest, cyclin B1, cdc2, protein sequestration, p53, colorectal cancer cells, mitosis initiation
- MeSH terms
- Cloning, Molecular, DNA Damage, Humans, Mitosis, Proteins, Tumor Cells, Cultured, Tyrosine 3-Monooxygenase, G2 Phase, Cell Cycle Proteins, Cyclin B, cdc25 Phosphatases, 14-3-3 Proteins, Cyclin B1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review